Spontaneous mutations in recombinant inbred mice:: Mutant toll-like receptor 4 (Tlr4) in BXD29 mice

被引:9
|
作者
Cook, DN
Whitehead, GS
Burch, LH
Berman, KG
Kapadia, Z
Wohlford-Lenane, C
Schwartz, DA
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Durham VAMC, Durham, NC 27710 USA
关键词
D O I
10.1534/genetics.105.042820
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Recombinant inbred (RI) mice are frequently used to identify QTL that underlie differences in measurable phenotypes between two inbred strains of mice. Here we show that one RI strain, C57BL/6J X DBA/2J (BXD29), does not develop an inflammatory response following inhalation of LPS. Approximately 25% of F-2 mice [F-1 (BXD29 X DBA/2J) X F-1] are also unresponsive to inhaled LPS, suggesting the presence Of a recessive mutation in the BXD29 strain. A genomic scan of these F-2 mice revealed that unresponsive animals, but not responsive animals, are homozygous for C57BL/6J DNA at a single locus oil chromosome 4 close to the genomic location of Tlr4. All progeny between BXD29 and gene-targeted Tlr4-deficient. mice are unresponsive to inhaled LPS, suggesting that the mutation in the BXD29 strain is allelic with Tlr4. Moreover, the intact Tlr4 receptor is not displayed on the cell surface of BXD29 macrophages. Finally, a molecular analysis of the tlr4 gene in BXD29 mice revealed that it is interrupted by a large insertion of repetitive DNA. These findings explain the unresponsiveness of BXD29 mice to LPS and suggest that data from BXD29 mice should not. be included when using BXD mice to study phenotypes affected by Tlr4 function. Our results also suggest that the frequency of such unidentified, spontaneously occurring mutations is an issue that should be considered when RI strains are Used to identify QTL.
引用
下载
收藏
页码:1751 / 1755
页数:5
相关论文
共 50 条
  • [21] Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, KO mice have neuroprotective effects against focal cerebral ischemia in mice
    Hyakkoku, Kana
    Tsuruma, Kazuhiro
    Shimazawa, Masamitsu
    Tanaka, Hiroyuki
    Uematsu, Satoshi
    Akira, Shizuo
    Nagai, Hiroichi
    Hara, Hideaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 225P - 225P
  • [22] Lactobacillus delbrueckii alleviates depression-like behavior through inhibiting toll-like receptor 4 (TLR4) signaling in mice
    Qiu, Xiangjie
    Wu, Guojun
    Wang, Lili
    Tan, Yurong
    Song, Zhi
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (05)
  • [23] Blocking receptor for advanced glycation end products (RAGE) or toll-like receptor 4 (TLR4) prevents posttraumatic epileptogenesis in mice
    Ping, Xingjie
    Chai, Zhi
    Wang, Weiping
    Ma, Cungen
    White, Fletcher F. A.
    Jin, Xiaoming
    EPILEPSIA, 2021, 62 (12) : 3105 - 3116
  • [24] Molecular Dynamics Simulation of Toll-Like Receptor 4 (TLR4) Ectodomain
    Tafazzol, Alireza
    Duan, Yong
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 339A - 339A
  • [25] Toll-like receptor 4 (TLR4) gene polymorphisms in celiac disease
    Santin, I.
    Castellanos-Rubio, A.
    Hualde, I.
    Castano, L.
    Vitoria, J. C.
    Bilbao, J. R.
    TISSUE ANTIGENS, 2007, 70 (06): : 495 - 498
  • [26] Toll-like receptor 4 (TLR4): new insight immune and aging
    Hyo-Jin Kim
    Hyemin Kim
    Jeong-Hyung Lee
    Cheol Hwangbo
    Immunity & Ageing, 20
  • [27] Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4)
    Smirnova, Irina
    Poltorak, Alexander
    Chan, Edward K. L.
    McBride, Colleen
    Beutler, Bruce
    GENOME BIOLOGY, 2000, 1 (01):
  • [28] A toll-like receptor 4 (TLR4) variant is associated with asthma severity
    Zhang, Long
    Xu, Ai-Guo
    Zhao, Wei
    Xu, Qin-Fu
    Zhao, Yu-Miao
    Li, Dan-Dan
    Shi, Xiao-Ya
    Zhao, Jun-Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 7849 - 7854
  • [29] Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease
    Vaez, Haleh
    Soraya, Hamid
    Garjani, Alireza
    Gholikhani, Tooba
    ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (01) : 36 - 47
  • [30] Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective
    Zhang, Yongsheng
    Liang, Xinjie
    Bao, Xuefei
    Xiao, Wei
    Chen, Guoliang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 235